Viewing Study NCT03190733


Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2026-03-02 @ 3:43 PM
Study NCT ID: NCT03190733
Status: UNKNOWN
Last Update Posted: 2017-06-19
First Post: 2017-06-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT
Sponsor: Zhujiang Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module